MED0924054
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924054 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 16:11
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
OBESITY PROFILE2.0-1036-1078
COMPLETE BLOOD COUNTS (CBC), WHOLE BLOOD EDTA
HAEMOGLOBIN 9.2 Low 11.0-14.0 g/dL
Method: Colorimetric SLS
HAEMATOCRIT 29.8 Low 34.0-40.0 %
Method: Calculated
RED BLOOD CELL COUNT 5.3 High 4.0-5.2 10^6/μL
Method: ELECTRICAL IMPEDANCE
MEAN CORPUSCULAR VOLUME 55.9 Low 75-87 fL
Method: Calculated
MEAN CORPUSCULAR HEMOGLOBIN 15.3 Low 24-30 pg
Method: Calculated
MEAN COR. HEMOGLOBIN CONCENTRATION 27.4 Low 31-37 g/dL
Method: Calculated
RED CELL DISTRIBUTION WIDTH 21.4 High 11.6-14.0 %
Method: DERIVED/COULTER PRINCIPLE
PLATELET COUNT 257 200-490 10^3/μL
Method: Electrical Impedance/ Microscopy
MEAN PLATELET VOLUME 8.0 6.5 - 12.0 fL
Method: DERIVED/COULTER PRINCIPLE
WHITE BLOOD CELL COUNT 3.3 Low 5.0-15.0 10^3/μL
Method: Laser-based flow cytometry/Microscopy
DIFFERENTIAL LEUCOCYTE COUNT
NEUTROPHILS 45 32-62 %
Method: Laser-based flow cytometry/Microscopy
ABSOLUTE NEUTROPHIL COUNT 1.49 1-7 10^3/μL
Method: CALCULATED PARAMETER
LYMPHOCYTES 50 27-57 %
Method: Laser-based flow cytometry/Microscopy
ABSOLUTE LYMPHOCYTE COUNT 1.65 Low 6-9 10^3/μL
Method: CALCULATED PARAMETER
EOSINOPHILS 02 0-3 %
Method: Laser-based flow cytometry/Microscopy
ABSOLUTE EOSINOPHIL COUNT 0.07 Low 0.1-1 10^3/μL
Method: CALCULATED PARAMETER
MONOCYTES 03 05 %
Method: Laser-based flow cytometry/Microscopy
ABSOLUTE MONOCYTE COUNT 0.1 Low 0.2-1 10^3/μL
Method: CALCULATED PARAMETER
BASOPHILS 00 0-1 %
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 1 of 8
MED0924054
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924054 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 16:11
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
Method: Laser-based flow cytometry/Microscopy
ABSOLUTE BASOPHIL COUNT 00 Low 0.02-0.1 10^3/μL
Method: CALCULATED PARAMETER
A complete blood count is a common blood test done for many reasons:
-To look at overall health. A complete blood count can be part of a medical exam to check general health and to look for
conditions, such as anemia or leukemia.
-To diagnose a medical condition. A complete blood count can help find the cause of symptoms such as weakness, fatigue and
fever. It also can help find the cause of swelling and pain, bruising, or bleeding.
-To check on a medical condition. A complete blood count can help keep an eye on conditions that affect blood cell counts.
-To check on medical treatment. A complete blood count may be used to keep an eye on treatment with medicines that affect
blood cell counts and radiation.
A Complete Blood Count (CBC) is a blood test that measures the number and characteristics of red blood cells, white blood cells,
and platelets in the blood. It's a routine test used to assess overall health, diagnose various conditions, and monitor treatment
effectiveness.
Key components measured in a CBC include:
Red blood cells (RBCs): These carry oxygen throughout the body.
White blood cells (WBCs): These help fight infections and other diseases.
Hemoglobin: A protein in red blood cells that carries oxygen.
Hematocrit: The percentage of red blood cells in the blood.
Platelets: These help with blood clotting.
"NOT FOR MEDICO-LEGAL PURPOSES"
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 2 of 8
MED0924054
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924054 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 16:11
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
HAEMATOLOGY
MALARIA BLOOD SMEAR
THICK SMEAR NOT SEEN NOT SEEN
Method: MICROSCOPIC
THIN SMEAR NOT SEEN NOT SEEN
Method: MICROSCOPIC
MALARIAL PARASITE (M.P)BLOOD/SMEAR-
Malaria is an acute and sometimes a chronic infestation of red blood cells by parasites of the genus Plasmodium.
Demonstration of these parasites in the blood smear establishes the diagnosis of malaria. Of the four species of plasmodia causing human malaria P. vivax and P. falciparum are commonly
encountered in India. Infection with the other species (P. malariae and P. ovale) is rare in India.Peripheral blood smear examination for detection of malaria parasite is highly specific but is less
sensitive (~85%). Malaria parasite may not be detected on peripheral blood smear if infestation rate is very low
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 3 of 8
MED0924054
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924054 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 18:11
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
GLYCOSYLATED HAEMOGLOBIN,(HBA1C)WHOLE BLOOD
GLYCOSYLATED HAEMOGLOBIN,WHOLE BLOOD
GLYCOSYLATED HEMOGLOBIN/HBA1C 5 NON DIABETIC: <5.7 %
Method: HPLC PRE DIABETICS :5.7-6.4
DIABETICS:>=6.5
ADA TARGET:7.0
ACTION SUGGESTED:>8.0
MEAN PLASMA GLUCOSE 96.8 <116.0 mg/dL
Method: Calculated
Comment :
HbA1c is a blood test that is used to diagnose type 2 diabetes. It is also used to monitor blood glucose control in people with diabetes.
HbA1c is short for glycated haemoglobin. The test is also sometimes called haemoglobin A1c.
Haemoglobin (Hb) is the protein in red blood cells that carries oxygen through your body. HbA1c refers to glucose and haemoglobin joined
together (the haemoglobin is ‘glycated’). The amount of HbA1c formed is directly related to the amount of glucose in your blood.
Red blood cells live for an average of 120 days, so HbA1c gives an indication of how much sugar there has been in your blood over the past
few months. It’s different to a blood glucose test, which measures how much sugar is in the blood at that moment.
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 4 of 8
MED0924053
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924053 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 17:06
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
OBESITY PROFILE2.0-1036-1078
LIVER FUNCTION TEST,SERUM
BILIRUBIN TOTAL 0.15 <2.0 mg/dL
Method: Diazo
BILIRUBIN DIRECT 0.10 0.0-0.4 mg/dL
Method: Diazo
BILIRUBIN INDIRECT 0.05 0.0-1.0 mg/dL
Method: Calculated
ASPARTATE AMINOTRANSFERASE/SGOT 58.8 High 00-45 U/L
Method: IFCC Without P5P
ALANINE AMINOTRANSFERASE/SGPT 45.3 High 00-35 U/L
Method: IFCC Without P5P
TOTAL PROTEIN,SERUM 6.68 5.6-7.5 g/dL
Method: Biuret
ALBUMIN,SERUM 4.17 3.8-5.4 g/dL
Method: Bromo Cresol Green (BCG)
GLOBULIN,SERUM 2.51 2.3 - 4.5 gm/dL
Method: Method : CALCULATED
A/G RATIO 1.66 0.8 - 2.1
ALKALINE PHOSPHATASE,SERUM 285 54-369 U/L
Method: AMP buffer
GAMMA GLUTAMYL TRANSFERASE 32.3 00-38 U/L
Method: Glupa C
Liver function tests are blood tests used to help find the cause of your symptoms and monitor liver disease or damage. The tests
measure the levels of certain enzymes and proteins in your blood.
Some of these tests measure how well the liver is performing its regular functions of producing protein and clearing bilirubin, a
blood waste product. Other liver function tests measure enzymes that liver cells release in response to damage or disease.
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 5 of 8
MED0924053
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924053 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 17:06
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
OBESITY PROFILE2.0-1036-1078
KIDNEY FUNCTION TEST,SERUM
CREATININE 0.32 0.3-0.7 mg/dL
Method: Enzymatic
BLOOD UREA 19.3 15.0-36.0 mg/dL
Method: Urease-GLDH
BLOOD UREA NITROGEN 9.01 6.0-21.0 mg/dL
Method: UREASE - UV
BUN/CREATININE RATIO 28.16 RATIO
Method: CALCULATED
URIC ACID 3.3 2.6-6.0 mg/dL
TOTAL PROTEIN 6.68 5.6-7.5 g/dL
Method: Biuret
ALBUMIN 4.17 3.8-5.4 g/dL
Method: Bromo Cresol Green (BCG)
GLOBULIN 2.51 2.30-4.50 g/dL
Method: Calculated
A/G RATIO 1.66 0.8 - 2.1
SODIUM 141.5 135.0-150.0 mmol/L
Method: ISE INDIRECT
POTASSIUM 4.29 3.5-5.0 mmol/L
Method: ISE Direct
CHLORIDE 100.5 94.0-110.0 mmol/L
Method: ISE Direct
SERUM BLOOD UREA NITROGEN
Causes of Increased levels Pre renal • High protein diet, Increased protein catabolism, GI haemorrhage, Cortisol, Dehydration, CHF Renal • Renal Failure .Post
Renal • Malignancy, Nephrolithiasis, Prostatism Causes of decreased levels - Liver disease, SIADH.
CREATININE, SERUM Higher than normal level may be due to:• Blockage in the urinary tract,• Kidney problems, such as kidney damage or failure, infection, or
reduced blood flow • Loss of body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures
(eclampsia)), or high blood pressure caused by pregnancy (preeclampsia) Lower than normal level may be due to:• Myasthenia Gravis • Muscular dystrophy.
URIC ACID, SERUM Causes of Increased levels • High Protein Intake.• Prolonged Fasting,• Rapid weight loss.Gout Lesch nyhan syndrome.Type 2 DM.Metabolic
syndrome.
Causes of decreased levels • Low Zinc Intake • OCP's • Multiple Sclerosis Nutritional tips to manage increased Uric acid levels • Drink plenty of fluids • Limit
animal proteins • High Fibre foods • Vit C Intake • Antioxidant rich foods.
TOTAL PROTEIN, SERUM Serum total protein,also known as total protein, is a biochemical test for measuring the total amount of protein in serum..Protein in
the plasma is made up of albumin and globulin Higher-than-normal levels may be due to: Chronic inflammation or infection, including HIV and hepatitis B or C,
Multiple myeloma, Waldenstrom's disease Lower-than-normal levels may be due to: Agammaglobulinemia, Bleeding (hemorrhage),Burns,Glomerulonephritis,
Liver disease, Malabsorption, Malnutrition, Nephrotic syndrome,Protein-losing enteropathy etc.
ALBUMIN, SERUM
Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum
protein. Low blood albumin levels (hypoalbuminemia) can be caused by: Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy,
Burns, hemodilution, increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc.
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 6 of 8
MED0924053
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924053 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:35 RECEIVED 08/08/2025 15:35 REPORTED 08/08/2025 17:08
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
OBESITY PROFILE2.0-1036-1078
ELECTROLYTES,SERUM
SODIUM 141.5 135.0-150.0 mmol/L
Method: ISE INDIRECT
POTASSIUM 4.29 3.5-5.0 mmol/L
Method: ISE Direct
CHLORIDE 100.5 94.0-110.0 mmol/L
Method: ISE Direct
TSH 3RD GEN.SERUM
TSH 3RD GEN. 0.796 0.3-4.5 uIU/mL
Method: CLIA
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 7 of 8
MED0924053
PATIENT NAME Baby. RIZA PATIENT ID 10336897
LAB NO MED0924053 AGE 2Y GENDER Female DATE OF BIRTH
DRAWN 08/08/2025 15:36 RECEIVED 08/08/2025 15:36 REPORTED 08/08/2025 17:00
REF. BY Dr. TASHKEEL Report Status Preliminary
PATIENT HISTORY
Investigations Result Biological Ref.Int. Unit
SEROLOGY
SEROLOGY
Widal Test Slide, Serum
S TYPHI O ANTIGEN TITRE 1:80 <1:80 TITER
Method: METHOD : AGGLUTINATION METHOD
S TYPHI H ANTIGEN TITRE <1:80 <1:80 TITER
Method: METHOD : AGGLUTINATION METHOD
S PARATYPHI AH ANTIGEN <1:80 <1:80 TITER
Method: METHOD : AGGLUTINATION METHOD
S PARATYPHI BH ANTIGEN <1:80 <1:80 TITER
Method: S PARATYPHI AH ANTIGEN
Results- SLIGHTY POSITIVE
WIDAL TEST
The Widal agglutination test is used for diagnosing Enteric Fever. The term enteric fever includes typhoid fever caused by Salmonella typhi, Salmonella paratyphi A, Band C.Though enteric fever is
endemic in all parts of India, S.paratyphi C infections are uncommon and are not included in Widal testing.The Widal test measures theantibodies against the 'H' (flagellar) & 'O' (somatic) antigens of typhoid and paratyphoid(A & B) bacilli
,in the patients sera. The test is performed in serially increasingdilutions.
- Diagnostic titre of Widal test varies highly between different geographical locations. It depends upon the baseline titre prevalent amongst the healthy individuals inthat geographical area, which in turn is influenced by endemicity of typhoid
in that region.
- The titre of the Widal test will epend on the stage of the disease. Antibodies usually appear by the beginning of second week of infection. Hence blood taken earliermay give a negative result. The titre increases steadily till the 3rd or 4th
week after which it declines gradually.
- Cases treated early with antibiotics may show a poor antibody response.
- A single Widal test is of little clinical relevance due to the number of cross reacting infections,including malaria,tuberculosis, pneumonia, amoebiasis, rickettsial
disease,Rheumatoid arthritis, hepatitis B. A fourfold increase in the titer in paired sera in the course of the infection would be consistent with a typhoid infection.
Typhoid is an enteric fever caused by salmonella such as S.typhi,Sparatyphi and paratyphi B. Symptoms are lightfeverstep ladder pattern.Severe headacke, nausea,anorexia and constipation later diarrhea, Brady cardiac leukopenia. Widal
test most widely accepted sero diagnostic technique for diagnosis of Typhoid. High agglutinin titers of O and H antibodies in serum of patients are detected and they are diagnostic .Agglutinin titer upto 1:80 are significant and greater suggests
infection .A four fold rise in titers between two serum samples at acute and convalescent phase are diagnostic.
"NOT FOR MEDICO-LEGAL PURPOSES"
*** End Of Report ***
Testing Done by Medimaa Diagnostics (An NABL Accredited Laboratory)
*Not for medico legal purpose.*
Page 8 of 8
